PL389357A1 - Tartaric acids derivatives imatinib salts and process for the preparation thereof - Google Patents

Tartaric acids derivatives imatinib salts and process for the preparation thereof

Info

Publication number
PL389357A1
PL389357A1 PL389357A PL38935709A PL389357A1 PL 389357 A1 PL389357 A1 PL 389357A1 PL 389357 A PL389357 A PL 389357A PL 38935709 A PL38935709 A PL 38935709A PL 389357 A1 PL389357 A1 PL 389357A1
Authority
PL
Poland
Prior art keywords
preparation
tartaric acids
acids derivatives
imatinib salts
imatinib
Prior art date
Application number
PL389357A
Other languages
Polish (pl)
Inventor
Tomasz Koźluk
Robert Woźniak
Original Assignee
Tomasz Koźluk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomasz Koźluk filed Critical Tomasz Koźluk
Priority to PL389357A priority Critical patent/PL389357A1/en
Priority to PCT/PL2010/000105 priority patent/WO2011049474A1/en
Priority to EP10784881A priority patent/EP2491027A1/en
Publication of PL389357A1 publication Critical patent/PL389357A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL389357A 2009-10-22 2009-10-22 Tartaric acids derivatives imatinib salts and process for the preparation thereof PL389357A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL389357A PL389357A1 (en) 2009-10-22 2009-10-22 Tartaric acids derivatives imatinib salts and process for the preparation thereof
PCT/PL2010/000105 WO2011049474A1 (en) 2009-10-22 2010-10-21 Salts of imatinib with tartaric acids
EP10784881A EP2491027A1 (en) 2009-10-22 2010-10-21 Salts of imatinib with tartaric acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL389357A PL389357A1 (en) 2009-10-22 2009-10-22 Tartaric acids derivatives imatinib salts and process for the preparation thereof

Publications (1)

Publication Number Publication Date
PL389357A1 true PL389357A1 (en) 2011-04-26

Family

ID=43415294

Family Applications (1)

Application Number Title Priority Date Filing Date
PL389357A PL389357A1 (en) 2009-10-22 2009-10-22 Tartaric acids derivatives imatinib salts and process for the preparation thereof

Country Status (3)

Country Link
EP (1) EP2491027A1 (en)
PL (1) PL389357A1 (en)
WO (1) WO2011049474A1 (en)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW225528B (en) 1992-04-03 1994-06-21 Ciba Geigy Ag
CO4940418A1 (en) 1997-07-18 2000-07-24 Novartis Ag MODIFICATION OF A CRYSTAL OF A DERIVATIVE OF N-PHENYL-2-PIRIMIDINAMINE, PROCESSES FOR ITS MANUFACTURE AND USE
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
WO2004106326A1 (en) 2003-06-02 2004-12-09 Hetero Drugs Limited Novel polymorphs of imatinib mesylate
AR047530A1 (en) 2004-02-04 2006-01-25 Novartis Ag FORMS OF SALT OF 4- (4-METHYLIPIPERAZIN-1-ILMETIL) -N- (4-METHYL-3- (4-PIRIDIN-3-IL) PIRIMIDIN-2-ILAMINO) PHENYL) -BENZAMIDA
UA84462C2 (en) 2004-04-02 2008-10-27 Институт Фармацевтични Crystalline polymorphs of methanesulfonic acid addition salts of imatinib
WO2006048890A1 (en) 2004-11-04 2006-05-11 Sun Pharmaceutical Industries Limited Imatinib mesylate crystal form and process for preparation thereof
WO2006054314A1 (en) 2004-11-17 2006-05-26 Natco Pharma Limited Polymorphic forms of imatinib mesylate
ES2334933T3 (en) 2005-08-15 2010-03-17 Siegfried Generics International Ag COVERED OR GRANULATED TABLET CONTAINING A PYRIDYL PIRIMIDINE.
BRPI0615383A2 (en) 2005-08-26 2011-05-17 Novartis Ag delta and epsilon crystal forms of imatinib mesylate
CN102351842B (en) 2005-11-25 2014-07-23 诺华股份有限公司 F,G,H,I and K crystal forms of imatinib mesylate

Also Published As

Publication number Publication date
WO2011049474A1 (en) 2011-04-28
EP2491027A1 (en) 2012-08-29

Similar Documents

Publication Publication Date Title
PL2362875T3 (en) Process for the production of alpha-tocotrienol and derivatives
PL2604267T3 (en) Process for the preparation of thiazole derivatives
EP2046751A4 (en) Process for preparing solifenacin and its salts
IL206390A0 (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
ZA201005350B (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
IL181607A0 (en) Novel process for preparing montelukast and salts thereof
IL220211A0 (en) Process for the preparation of 1-alkyl-/1-aryl-5-pyrazolecarboxylic acid derivatives
IL201670A0 (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
PL2151428T3 (en) Process for the preparation of agomelatin
HUP0800766A2 (en) Process for the preparation of piperazine derivatives
ZA201201237B (en) Process for preparing decanecarboxylic acids
ZA201106628B (en) Process for the preparation of propionic acid derivatives
EG26332A (en) Process for the preparation of benzonorbornenes
SI2477964T1 (en) Process for preparing alpha-carboxamide derivatives
IL205082A0 (en) Process for the preparation of tetranorlabdane derivatives
IL219138A0 (en) Process for the preparation of 4-sulfinyl-pyrazole derivatives
PT2151429E (en) Process for the preparation of agomelatin
ZA201105124B (en) Process for the preparation of rosuvastatin salts
IL207557A0 (en) Process for the preparation of pregnane derivatives
ZA201006884B (en) Process for the preparation of donepezil hydrochloride
GB2464854B (en) Process for the preparation of risperidone
ZA201205062B (en) Process for the preparation of propionic acid derivatives
GB0816754D0 (en) Process for the preparation of anthranilamide derivatives
PL389357A1 (en) Tartaric acids derivatives imatinib salts and process for the preparation thereof
PT2419407E (en) Improved process for the preparation of fluvastatin and salts thereof

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)